Anzeige
Mehr »
Login
Freitag, 26.04.2024 Börsentäglich über 12.000 News von 686 internationalen Medien
Geheimtipp: Rasanter Aufstieg, Branchenrevolution und Jahresumsatz von 50 Mio. $
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
36 Leser
Artikel bewerten:
(0)

Elsevier Launches PracticeUpdate Metastatic Breast Cancer Center of Excellence

PHILADELPHIA, July 6, 2016 /PRNewswire/ --

Free Virtual Institute and Online Community Focuses on Diagnosis and Treatment of Metastatic Breast Cancer

Elsevier, a world-leading provider of scientific, technical, and medical information products and services, today announced that it has launched its newest PracticeUpdate Center of Excellence (COE) focused on metastatic breast cancer.

The COE, an important new benefit for PracticeUpdate members, brings together medical experts in oncology to discuss and provide relevant treatment advice and disease information on metastatic breast cancer.

"PracticeUpdate.com provides a virtual COE in the treatment of metastatic breast cancer that leverages technology to create a collaborative and comprehensive way to improve patient care," said Lee S. Schwartzberg, MD, FACP, PracticeUpdate Editor-in-Chief. "This unique center has the key advantages of a real-world academic center that fosters an expert-led team approach to help clinicians stay well-informed of the latest research, treatment options and approaches for metastatic breast cancer."

Among the features of PracticeUpdate's Metastatic Breast Cancer COE are:

  • Tumor boards: join interactive, ongoing patient case discussions with peers and COE faculty.
  • Colleague insights: gain insights from PracticeUpdate's expert faculty, who select and connect on important articles from all of the top oncology journals.
  • Living resources: stay current with free oncology textbook chapters, simplified guidelines, seminal articles and frequently asked questions.
  • Conferences: benefit from expert reports on metastatic breast cancer from major oncology conferences.
  • Nursing perspectives: engage with new research and content for advanced practice oncology nurses.

Dr Schwartzberg is proudly joined by Associate Editor Lillie D. Shockney, RN, BS, MAS, Administrative Director, Johns Hopkins Breast Center and Cancer Survivorship Programs.

"With the expanding usage of PracticeUpdate by Nurses, PAs and NPs, I feel very fortunate to have Lillie Shockney providing her expert insights and nursing perspectives to our Center of Excellence," Schwartzberg said.

PracticeUpdate.com is a free destination for physicians to access distilled, expert"selected professional research, articles, and education - with insights and analysis from credible opinion leaders in their field. The site provides a highly customized experience for its members by tailoring its content to each user's chosen specialty and communication preferences. For additional information on the Metastatic Breast Cancer Center of Excellence, please visit http://www.mbc.practiceupdate.com.

About Elsevier

Elsevier is a world-leading provider of information solutions that enhance the performance of science, health, and technology professionals, empowering them to make better decisions, deliver better care, and sometimes make groundbreaking discoveries that advance the boundaries of knowledge and human progress. Elsevier provides web-based, digital solutions - among them ScienceDirect, Scopus, Elsevier Research Intelligenceand ClinicalKey - and publishes over 2,500 journals, including The Lancet and Cell, and more than 35,000 book titles, including a number of iconic reference works. Elsevier is part of RELX Group, a world-leading provider of information and analytics for professional and business customers across industries.http://www.elsevier.com

Media contact:
Chris Capot
Director, Corporate Relations, Elsevier
+1-917-704-5174
c.capot@elsevier.com

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2016 PR Newswire
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.